To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Foam, 0.005%/0.064%, in the Treatment of Psoriasis Vulgaris (Plaque Psoriasis).
Clinical trial NCT03731091 · COMPLETED
Trial details
- NCT number
- NCT03731091
- Sponsor
- Glenmark Pharmaceuticals Ltd. India
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-31
- Primary completion
- 2020-03-17
- Enrollment
- 494
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.